gvtcx

National Framework Agreement for the supply of Recombinant Factor VIII products for the treatment of bleeding disorders

NHS England Published 21 Aug 2017 Contracts Finder
The value below is a framework or dynamic market ceiling: the maximum that could be spent across all call-offs, not the value of a single contract. Aggregate figures on this site exclude these to avoid double counting.

key details

Value£302,000,000
Statuscomplete
Category (CPV) 33141530
RegionNorth East, North West, Yorkshire and the Humber, East Midlands, West Midlands, East of England, London, South East, South West, Scotland, Wales, Northern Ireland
Deadline22 Sept 2017
Contract start1 Feb 2018
Contract end31 Jan 2019
Procedureopen
SME suitableNo
OCIDocds-b5fd17-da3b67f1-375b-4dc1-b407-bbddda599147

Awards (5)

This procurement was awarded to 5 suppliers. Values shown are per-award; the notice total is £302,000,000.

SupplierValueDateStatus
Baxalta Limited shared £302,000,000 24 Nov 2017 active
Bayer Plc shared £302,000,000 24 Nov 2017 active
Novo Nordisk Limited shared £302,000,000 24 Nov 2017 active
Octapharma Limited shared £302,000,000 24 Nov 2017 active
Pfizer Limited shared £302,000,000 24 Nov 2017 active

description

NHS framework agreement for the supply of Recombinant Factor VIII products for the treatment of bleeding disorders. The framework will commence on 1.2.2018 for a period of 12 months until 31.1.2019 with options to extend up to a further 17 months.

documents

Documents are linked, not mirrored. They are served by the publishing authority and may require registration.

notice history

1 notice published against this procurement.

PublishedTypeRegimeNotice
19 Dec 2017 Award (award) · 6bab93eb-e9a0-4819-a8d7-210a780e9a11-187830

more from NHS England

all contracts from this buyer →

similar contracts awarded

Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.

source

Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.